![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ResMed Finalizes $800M Brightree Acquisition
ResMed Finalizes $800M Brightree Acquisition
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/GreenDollarSign.gif?t=1433864063&width=430)
San Diego-based ResMed has finalized its acquisition of cloud healthcare software company Brightree for $800 million, the company reported Monday in an SEC filing.
The companies announced the acquisition in February.
Brightree specializes in post-acute care-focused clinical software applications. The Atlanta-based company will keep its name and continue to operate as a separate entity. — Anisa Jibrell
Upcoming Events
-
21Oct